| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000036590 |
| Receipt No. | R000041627 |
| Scientific Title | Efficacy test of supplements containing plant extract for Japanese |
| Date of disclosure of the study information | 2020/05/08 |
| Last modified on | 2019/05/15 (Ver. 11) |
| Basic information | ||
| Public title | Efficacy test of supplements containing plant extract for Japanese | |
| Acronym | Efficacy test of supplements containing plant extract for Japanese | |
| Scientific Title | Efficacy test of supplements containing plant extract for Japanese | |
| Scientific Title:Acronym | Efficacy test of supplements containing plant extract for Japanese | |
| Region |
|
|
| Condition | ||
| Condition | Healthy Japanese adult | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The objective of this study is to verify the effects on body fat of test foods in adult men and women of BMI 25 and under 30 and abdominal visceral fat area (VFA) 80 cm^2. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Body fat percentage and change
Neutral fat and change |
| Key secondary outcomes | Weight and change
BMI and change Waist circumference and change Hip circumference and amount of change |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of plant extract-containing food for 12 weeks | |
| Interventions/Control_2 | Intake of plant extract free food for 12 weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Persons aged 20 to 65 years of age at the time of obtaining informed consent
2) A healthy person who is not currently treating any disease 3) Persons with BMI of 25.0 kg / m2 or more and less than 30.0 kg / m2 at screening 4) Persons with a VFA of 80 cm2 or more using a CT scanner system 5) Those who can visit the designated medical institution on the scheduled examination date 6) A person who agreed in writing after fully understanding the purpose and content of this study |
|||
| Key exclusion criteria | 1) Those who have difficulty participating in the study due to liver, kidney, heart disease, respiratory disorder, endocrine disorder, metabolic disorder, neurological disorder, consciousness disorder, diabetes (according to the criteria established by the Japan Diabetes Association), and other diseases.
2) Person with a history of cardiovascular disease 3) Those who are taking glucose metabolism, lipid metabolism, blood pressure improvement drugs 4) Those who regularly use medicines and health foods / supplements (including foods for specified health, functional labeling foods and nutritionally functional foods) that may affect this study (but stop taking it at the time of obtaining consent) The person who can do it does not correspond) 5) Persons who have allergies related to the test food 6) Those who have experienced poor mood or physical condition by blood collection in the past 7) Those who donated more than 200 mL from the month before the start of the test to the start of the test 8) Those who are participating in other clinical trials or within 4 weeks after the trial 9) Alcoholic drinkers and excessive smokers 10) Eating habits are extremely irregular 11) Those who wish to become pregnant during the study period, pregnant women (including those who may be pregnant) or those who are lactating 12) Those who can not agree with the purpose of the description of this exam that is conducted in advance In addition, those who were judged inappropriate for this study by the study investigator |
|||
| Target sample size | 40 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | RYUSENDO CO., LTD. | ||||||
| Division name | President and CEO | ||||||
| Zip code | 171-0021 | ||||||
| Address | 1-5-3 Nishi-ikebukuro, Toshima-ku, Tokyo 171-0021, Japan | ||||||
| TEL | 03-3985-8346 | ||||||
| y.shiojima@ryusendo.co.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | RYUSENDO CO., LTD. | ||||||
| Division name | Development Office | ||||||
| Zip code | 171-0021 | ||||||
| Address | 1-5-3 Nishi-ikebukuro, Toshima-ku, Tokyo 171-0021, Japan | ||||||
| TEL | 03-3985-8346 | ||||||
| Homepage URL | |||||||
| m.takahashi@ryusendo.co.jp | |||||||
| Sponsor | |
| Institute | KYOWA TRIAL CO., LTD |
| Institute | |
| Department | |
| Funding Source | |
| Organization | RYUSENDO CO., LTD. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Akanuma Surgeon Board Ethics Review Committee |
| Address | Ishiyama 2-jo 6-chome 14-1, Minami-ku, Sapporo-shi, Hokkaido |
| Tel | 011-591-1777 |
| s-ito@kyowa-t.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 赤沼外科医院(北海道) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 0 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041627 |